Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.86 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 3/20 | 0.81 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.81 |
| ▸ | AURKA | O14965 | 2/20 | 0.81 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.81 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinyl-Coa SCHEMBL30927108 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL28138807 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL31385487 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL50744 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL4360979 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL4360968 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL28059593 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL4364428 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL31108060 | 0.98 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Succinyl-Coa SCHEMBL5529148 | 0.98 | NAA50 (0.84) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107095649-B | Metabolism evaluation system | 董云鹏 | 2020-07-24 | — | — | CN | disclosed |
| US-9421262-B2 | Compositions and methods for treating dermatological conditions | BIOMED RESEARCH & TECHNOLOGIES, INC. (US) | 2016-08-23 | — | — | US | disclosed |
| WO-2011051813-A1 | COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL CONDITIONS | PAUL HARBHAJAN S (US) | 2011-05-05 | — | — | WO | disclosed |
| US-20110098229-A1 | COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL CONDITIONS | BIOMED RESEARCH & TECHNOLOGIES, INC. | 2011-04-28 | — | — | US | disclosed |
| EP-1098630-B1 | COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION | BIOMED RES AND TECHNOLOGIES IN (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1098630-A2 | COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION | Biomed Research and Technologies, Inc. (US) | 2001-05-16 | — | — | EP | disclosed |
| US-6149924-A | FOR TOPICAL APPLICATION | BIOMED RESEARCH & TECHNOLOGIES, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| WO-2000004870-A2 | COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION | BIOMED RESEARCH AND TECHNOLOGIES, INC. (US) | 2000-02-03 | — | — | WO | disclosed |